Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study
about
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progressionHigh MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanomaCold-inducible proteins CIRP and RBM3, a unique couple with activities far beyond the coldDissecting the expression landscape of RNA-binding proteins in human cancersNuclear T-STAR protein expression correlates with HER2 status, hormone receptor negativity and prolonged recurrence free survival in primary breast cancer and decreased cancer cell growth in vitro.Evaluating real-time immunohistochemistry on multiple tissue samples, multiple targets and multiple antibody labeling methods.RNA binding motif protein 3: a potential biomarker in cancer and therapeutic target in neuroprotection.Proteome-wide epitope mapping of antibodies using ultra-dense peptide arraysHigh expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.A tool to facilitate clinical biomarker studies--a tissue dictionary based on the Human Protein Atlas.Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.Modifying effect of gender on the prognostic value of clinicopathological factors and Ki67 expression in melanoma: a population-based cohort study.Construction and analysis of multiparameter prognostic models for melanoma outcomeRNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cellsPodocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.Tissue prognostic biomarkers in primary cutaneous melanoma.Regulation of Stem Cell Self-Renewal and Oncogenesis by RNA-Binding Proteins.Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study.High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.The human gastrointestinal tract-specific transcriptome and proteome as defined by RNA sequencing and antibody-based profiling.Spatiotemporal profile and essential role of RBM3 expression after spinal cord injury in adult rats.High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer.Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification.Morphoregulatory functions of the RNA-binding motif protein 3 in cell spreading, polarity and migration.High RNA-binding Motif Protein 3 Expression Is Associated with Improved Clinical Outcomes in Invasive Breast CancerReduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome
P2860
Q21203667-70CE814F-D255-499B-9CCF-40F73E83CAC6Q27498879-C26EBA55-7D81-4BA2-974A-24E7011952C4Q28079941-ABC10420-4049-421A-ADEE-8FC3D24F227EQ28305624-6504507C-1D7C-4F30-A2F7-D495E0BC9756Q30009589-D4D25723-C0C4-4CE5-85D8-AF589E6862C7Q31146406-2547CCD9-16E2-4F59-8E5D-4F5FCF2AE847Q33591883-9F7225DC-22E6-4721-851D-2B2DAE4E07BAQ33718734-556A48B3-8BBB-4641-8746-69A6A7590EBDQ33794854-32646310-51EF-413A-A9BD-6429276F4182Q34413280-30F4EABE-58AB-48D0-8FC9-D1752186D62AQ34658794-DFFFBD47-A2E5-4EB3-9F14-AA7727C955EDQ35219992-586C0B42-3B64-4308-9011-2E8108FAC4B1Q36162586-33B276E3-8005-4B5D-93F4-1751CC3AFB46Q37550749-569F4CA1-78C2-4047-AA9A-D2D292F6ED9BQ37611494-A07E270A-1FAE-4CCC-B6D0-D60683D61A57Q37697790-6F6FE425-71DC-481C-BD2C-181D7600617CQ38184377-FF26BD39-40C8-4B9C-AE99-C7B53DE3AFB9Q38852157-4B1FBF97-FFBD-434E-8B2E-24280E260051Q41117948-36EFDACA-3DFF-4CBF-B3FD-88880E03DF0BQ41363245-7D7E7656-ED77-4B4F-A6A6-2943E9F06303Q42658326-F842A8F7-E63A-4D67-ABCD-55BA726FB3B5Q45323322-EE5D1DFE-22B6-4F65-B6B9-5DBF24EFF5B2Q47268922-C83CF895-AE15-4DE4-9603-06DB81D6B37FQ49787574-8348D44A-4A82-44ED-8FFF-75483FD27900Q54979442-BBB565F7-9899-4232-885B-A914BCBCB7DFQ57124774-414A1D95-C1E6-4872-8A9A-099F650BE3C9Q59136204-EAA03799-FFFC-4D00-8836-2B09D6993AA4
P2860
Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Low RBM3 protein expression co ...... he Malmö Diet and Cancer Study
@ast
Low RBM3 protein expression co ...... he Malmö Diet and Cancer Study
@en
type
label
Low RBM3 protein expression co ...... he Malmö Diet and Cancer Study
@ast
Low RBM3 protein expression co ...... he Malmö Diet and Cancer Study
@en
prefLabel
Low RBM3 protein expression co ...... he Malmö Diet and Cancer Study
@ast
Low RBM3 protein expression co ...... he Malmö Diet and Cancer Study
@en
P2093
P2860
P50
P356
P1476
Low RBM3 protein expression co ...... he Malmö Diet and Cancer Study
@en
P2093
Jonas Manjer
Julia Bergman
Liv Jonsson
P2860
P2888
P356
10.1186/1479-5876-9-114
P577
2011-07-21T00:00:00Z
P5875
P6179
1020851919